Ji Eun Won
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- MicroRNA in disease regulation
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Hee Dong Han (13 shared papers)Tae Heung Kang (8 shared papers)Jeong‐Won Lee (7 shared papers)Byung Cheol Shin (5 shared papers)Yeong‐Min Park (7 shared papers)Jae Myeong Lee (4 shared papers)Yeongseon Byeon (4 shared papers)Ga Hee Kim (3 shared papers)
- Journals
- Cancer Research (2 papers)Journal of Ginseng Research (2 papers)Theranostics (1 paper)Toxicology and Applied Pharmacology (1 paper)Journal of Biomedical Nanotechnology (1 paper)
- Partner nations
- South KoreaUnited StatesAustralia
In The Last Decade
Ji Eun Won
16 papers receiving 436 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 110
- Cancer Research 61
- Immunology 75
- Pharmaceutical Science 22
- Molecular Medicine 18
Countries citing papers authored by Ji Eun Won
This map shows the geographic impact of Ji Eun Won's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Eun Won with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Eun Won more than expected).
Fields of papers citing papers by Ji Eun Won
This network shows the impact of papers produced by Ji Eun Won. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Eun Won. The network helps show where Ji Eun Won may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Eun Won, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 114 | |
| 2 | 2018 | 64 | |
| 3 | 2020 | 57 | |
| 4 | 2021 | 46 | |
| 5 | 2022 | 28 | |
| 6 | 2020 | 22 | |
| 7 | 2020 | 15 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 13 | |
| 11 | 2023 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2019 | 12 | |
| 14 | 2021 | 10 | |
| 15 | 2025 | 6 | |
| 16 | 2022 | 1 |
About Ji Eun Won
Ji Eun Won is a scholar working on Biomaterials, Immunology, Molecular Biology, Oncology and Biomedical Engineering, having authored 16 papers that have together received 440 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), Nanoplatforms for cancer theranostics (3 papers), RNA Interference and Gene Delivery (3 papers), CRISPR and Genetic Engineering (1 paper), Angiogenesis and VEGF in Cancer (1 paper), RNA modifications and cancer (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Biomaterials (110 citations), Cancer Research (61 citations), Immunology (75 citations), Pharmaceutical Science (22 citations) and Molecular Medicine (18 citations). Ji Eun Won has collaborated with scholars based in South Korea, United States and Australia. Frequent co-authors include Hee Dong Han, Tae Heung Kang, Jeong‐Won Lee, Byung Cheol Shin, Yeong‐Min Park, Jae Myeong Lee, Yeongseon Byeon, Ga Hee Kim, Anil K. Sood and Chan Mi Lee. Their work appears in journals such as Cancer Research, Journal of Ginseng Research, Theranostics, Toxicology and Applied Pharmacology and Journal of Biomedical Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.